Literature DB >> 20135087

Where do the leukaemia relapses come from?

Arndt Borkhardt1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20135087     DOI： 10.1007/s00109-010-0593-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  16 in total

1.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

Review 2.  Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Authors:  M Brüggemann; A Schrauder; T Raff; H Pfeifer; M Dworzak; O G Ottmann; V Asnafi; A Baruchel; R Bassan; Y Benoit; A Biondi; H Cavé; H Dombret; A K Fielding; R Foà; N Gökbuget; A H Goldstone; N Goulden; G Henze; D Hoelzer; G E Janka-Schaub; E A Macintyre; R Pieters; A Rambaldi; J-M Ribera; K Schmiegelow; O Spinelli; J Stary; A von Stackelberg; M Kneba; M Schrappe; J J M van Dongen
Journal:  Leukemia       Date:  2009-12-24       Impact factor: 11.528

Review 3.  Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.

Authors:  Jyoti A Kode; Shayanti Mukherjee; Mugdha V Joglekar; Anandwardhan A Hardikar
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

4.  Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.

Authors:  Meike Fischer; Maike Schwieger; Stefan Horn; Birte Niebuhr; Anthony Ford; Susanne Roscher; Ulla Bergholz; Mel Greaves; Jürgen Löhler; Carol Stocking
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

5.  c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.

Authors:  Jay L Hess; Claudia B Bittner; Deniz T Zeisig; Christian Bach; Uta Fuchs; Arndt Borkhardt; Jon Frampton; Robert K Slany
Journal:  Blood       Date:  2006-02-28       Impact factor: 22.113

6.  Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia.

Authors:  Shabnam Shalapour; Cornelia Eckert; Karl Seeger; Madlen Pfau; Javier Prada; Günter Henze; Thomas Blankenstein; Thomas Kammertoens
Journal:  J Mol Med (Berl)       Date:  2010-02-14       Impact factor: 4.599

7.  Chromosome translocations and covert leukemic clones are generated during normal fetal development.

Authors:  Hiroshi Mori; Susan M Colman; Zhijian Xiao; Anthony M Ford; Lyn E Healy; Craig Donaldson; Jill M Hows; Cristina Navarrete; Mel Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

8.  Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.

Authors:  Pablo Menendez; Purificación Catalina; René Rodríguez; Gustavo J Melen; Clara Bueno; Mar Arriero; Félix García-Sánchez; Alvaro Lassaletta; Ramón García-Sanz; Javier García-Castro
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

9.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

10.  Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Letha A Phillips; Xiaoping Su; Jing Ma; Christopher B Miller; Sheila A Shurtleff; James R Downing
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.